Unlikely Foe Gets AbbVie To Alter Humira Marketing Practices In California
Under $24m settlement with the California Department of Insurance, AbbVie’s nurse ‘ambassadors’ cannot participate in conversations between patients and insurance companies and must disclose that they are paid by the company.
You may also be interested in...
First suit challenging biosimilar litigation settlements ratchets up pressure on AbbVie's "patent thicket" and licensing strategy.
California Insurance Commissioner claims AbbVie gave kickbacks for healthcare providers to prescribe Humira and had nurse 'ambassadors' insert themselves between patients and physicians.
Magistrate judge says Boehringer's theory 'may or may not be viable' as an infringement defense; permits third party subpoenas for information on clinical trials.